 |
|
Drug shown to provide much needed alternative therapy for chronic shoulder pain
March 27, 2006Fills gap left by Cox-2 inhibitors
After the rise in safety concerns surrounding Vioxx and other Cox-2 inhibitors, people suffering from chronic shoulder pain were left with just two therapy options at opposite extremes-take Advil, or have surgery. But a new study from Columbia University Medical Center shows that sodium hyaluronate, a drug that is FDA-approved for osteoarthritis of the knee, is also effective for shoulder pain.
The study was presented today at the American Academy of Orthopaedic Surgeons annual meeting in Chicago by Theodore Blaine, M.D., assistant professor of orthopaedic surgery at Columbia University Medical Center and an attending surgeon at NewYork-Presbyterian Hospital.
The study showed that in patients with osteoarthritis of the shoulder, sodium hyaluronate was effective in reducing chronic pain by nearly 50 percent. The results were comparable to the 1998 study that led the FDA to approve the drug's use in treating knee pain. The FDA is currently reviewing the results in shoulder pain.
"Chronic shoulder pain is a common problem that can not adequately be treated with existing FDA-approved therapies," said Dr. Blaine, who was the principal investigator of the study. "The results of the trial were very encouraging, and we hope will lead to this drug's approval as an effective therapy for thousands of suffering patients."
According to the National Institute of Musculoskeletal and Skin Diseases, shoulder problems account for about 1.5 million visits to orthopaedic surgeons annually. The pain can be caused by a variety of problems, including osteoarthritis or rotator cuff tears.
Sodium hyaluronate is a vital building block of normal cartilage. It is marketed under the name Hyalgan by Sanofi Aventis.
All of the patients in the study had previously tried nonsurgical clinical interventions-including physical therapy, at least one steroid injection, and various oral pain medications-but the pain persisted. At the beginning of the study patients received an x-ray of the shoulder to confirm the diagnosis of osteoarthritis and rule out fractures or other exclusionary criteria, as well as an MRI to diagnose soft tissue and bony pathology or a tear in the rotator cuff.
The 602 patients who comprised the study population were broken up into three groups. One group received five injections of the drug over six months. A second group received three injections, followed by two saline injections, and the third group received just a placebo of five saline injections.
Throughout the six month trial, the patients were asked to record their level of pain on a scale of one to 100 - with 100 being the worst pain imaginable. All three groups began with an average baseline score of 65. Patients with osteoarthritis who received sodium hyaluronate saw the greatest decrease in their pain scores, which was reduced to a score of 35 in six months. The patients who received three injections ended up with a pain score of around 37.
The patients who received saline also saw a decrease, to around 43. The improvement in the saline group could be the result of the placebo effect, as well as the possible therapeutic benefit of irrigating the joint. Similar saline results were seen in the study that led to the drug's approval for knee pain.
No safety concerns arose during the study, which is particularly notable given that the patients were older and more likely to be on other medications and have additional diseases. Sixty percent of the patients were taking cardiac medications, approximately 55 percent took Cox-2 inhibitors prior to joining the study, and up to 14 percent were taking medication for diabetes.
Columbia University Medical Center
The study showed that in patients with osteoarthritis of the shoulder, sodium hyaluronate was effective in reducing chronic pain by nearly 50 percent. The results were comparable to the 1998 study that led the FDA to approve the drug's use in treating knee pain. The FDA is currently reviewing the results in shoulder pain.
"Chronic shoulder pain is a common problem that can not adequately be treated with existing FDA-approved therapies," said Dr. Blaine, who was the principal investigator of the study. "The results of the trial were very encouraging, and we hope will lead to this drug's approval as an effective therapy for thousands of suffering patients."
According to the National Institute of Musculoskeletal and Skin Diseases, shoulder problems account for about 1.5 million visits to orthopaedic surgeons annually. The pain can be caused by a variety of problems, including osteoarthritis or rotator cuff tears.
Sodium hyaluronate is a vital building block of normal cartilage. It is marketed under the name Hyalgan by Sanofi Aventis.
All of the patients in the study had previously tried nonsurgical clinical interventions-including physical therapy, at least one steroid injection, and various oral pain medications-but the pain persisted. At the beginning of the study patients received an x-ray of the shoulder to confirm the diagnosis of osteoarthritis and rule out fractures or other exclusionary criteria, as well as an MRI to diagnose soft tissue and bony pathology or a tear in the rotator cuff.
The 602 patients who comprised the study population were broken up into three groups. One group received five injections of the drug over six months. A second group received three injections, followed by two saline injections, and the third group received just a placebo of five saline injections.
Throughout the six month trial, the patients were asked to record their level of pain on a scale of one to 100 - with 100 being the worst pain imaginable. All three groups began with an average baseline score of 65. Patients with osteoarthritis who received sodium hyaluronate saw the greatest decrease in their pain scores, which was reduced to a score of 35 in six months. The patients who received three injections ended up with a pain score of around 37.
The patients who received saline also saw a decrease, to around 43. The improvement in the saline group could be the result of the placebo effect, as well as the possible therapeutic benefit of irrigating the joint. Similar saline results were seen in the study that led to the drug's approval for knee pain.
No safety concerns arose during the study, which is particularly notable given that the patients were older and more likely to be on other medications and have additional diseases. Sixty percent of the patients were taking cardiac medications, approximately 55 percent took Cox-2 inhibitors prior to joining the study, and up to 14 percent were taking medication for diabetes.
Columbia University Medical Center
More Chronic Shoulder Pain Current Events and Chronic Shoulder Pain News Articles
 | Working with Neck and Shoulder Pain (Mindful Healing) This interactive and educational CD will help you experience more peace and balance and peace as you live with neck and shoulder pain. It will also introduce you to mindfulness meditation practices and teach you simple and yet profound tools that have the potential to decrease neck and shoulder pain. For more information please visit... |
 | The Pain-Free Program: A Proven Method to Relieve Back, Neck, Shoulder, and Joint Pain by Anthony B. Carey "Anthony Carey hits the bull's-eye! Striving for a pain-free lifestyle is a goal we all want to achieve, and this book is a powerful tool to help you attain it." --Bradford Stiles, M.D., Medical Director of California Sports & Industrial Medical Center "Anthony Carey's unique approach to promote the proper function of the whole body in order to support and heal the problematic area... |
 | "Guide To Back Pain" Techniques to make your Back Pain Disappear Would you like to have the almost magical ability to quickly and easily end your back pain any time you want? Does the idea of not having to pay for expensive chiropractor visits excite you? Do you want to be in the enviable position of always being free of back pain (plus having increased range of motion) no matter which activities you choose to participate in? If so, you can be well on... |
 | Chronic Pain Self-treatment Including Carpal Tunnel Syndrome by Bernard Schatz P.T. |
 | Treat Your Own Rotator Cuff by Jim Johnson Based entirely on research from peer-reviewed journals and randomized controlled trials, Treat Your Own Rotator Cuff is a complete program to prevent and rehabilitate rotator cuff injuries for athletes and non-athletes alike. In less than 100 pages, readers will learn precisely how the rotator cuff works, what can go wrong with it, and then are guided step-by-step through an evidence-based... |
 | Our Silent Epidemic - Children's Deformed Fingers from Video Gaming by Mike Tomich Our mission is to inform you of our recent discovery of why children develop bent/twisted finger deformities from video gaming, coloring, and computers. Why adults experience the same type of deformities, in addition to physical pain from using chain saws to driving certain "high effort steering" vehicles. [Impala, Mustang, Durango, Cavalier, Chrysler 300, SUV's, etc.] A 5 year study, combining... |
| © 2008 BrightSurf.com |